home
portfolio
team
careers
contact
investor portal
home
portfolio
team
careers
contact
investor portal
Nextech Invest
Kinnate Biopharma Inc. Announces FDA Clearance of Investigational Drug Application for KIN-3248
Kinnate Biopharma Inc. Announces FDA Clearance of Investigational Drug Application for KIN-3248
Post navigation
Previous Post
Previous
Amgen and Arrakis Therapeutics Announce Multi-Target Collaboration to Identify Novel RNA Degrader Small Molecule Therapeutics
Next Post
Next
Scorpion Therapeutics Enters Agreement with Astrazeneca to Discover, Develop and Commercialize Novel Cancer Treatments Against Undruggable Targets